More Evidence That Topamax Manufacturer Is Responsible For Birth Defects

I've written a lot about the serious problems associated with use of Topamax during pregnancy.  After all, the FDA ordered Topamax to be re-labelled and re-classified in March, 2011 in response to data suggesting a conclusive correlation between Topamax usage by pregnant woman and birth defects such as: cleft lip, cleft palate, Spina Bifida, facial defects and pediatric heart problems. The swift decision to change the classification / labelling of Topamax is mainly due to the data collected by the FDA.  The FDA collects information about Continue reading

New FDA Warnings Suggest Correlation Between Topomax And Birth Defects Including: Cleft Lip & Cleft Palate

A new FDA warning was recently published which warns women of childbearing age that their use of Topomax (and other generic variations known as topiramate) significantly increases their chances of giving birth to a child with mouth-related birth defects. Topiramate is a widely used prescription medication used to control epilepsy and severe headaches. Women taking Topomax were more than three times more likely to give birth to a child with birth defects related to a child’s mouth such as: cleft lip or cleft palate compared with women Continue reading